NEW YORK ( TheStreet) -- First Trust NYSE Bio-technology ( FBT) and SPDR KBW Regional Banking ETF ( KRE) offer two ways to avoid political fallout from the passage of the health care reform bill.

As I have discussed in the past, ETF investors can avoid the political mayhem in the sectors that the bill is directed toward by choosing health care ETFs that focus on bio-tech companies, such as FBT, and financial ETFs that include regional banks such KRE. Year to date, FBT has risen 29.4% while KRE has gone up by 18.7%.

These sub-sectors of health care and financials fall outside the scope of President Obama's reform agenda and will likely see continued upward momentum regardless of the action in Washington.

Late Sunday, the House approved the health care reform bill, clearing the way for an overhaul of the sector after a long, controversial political battle.

If the lobbying efforts of the pharmaceuticals are a good indicator, iShares Dow Jones U.S. Pharmaceuticals ( IHE) should benefit. These companies are expected to benefit from the increase demand for pharmaceuticals from the addition of Americans to insurance rolls.

Similarly, biotechnology, which wasn't a target of the legislation, is likely to benefit from higher levels of spending.

The passage of the bill also affects ETFs that would benefit or suffer from legislation that Obama plans on fighting for later this year.

The protests against the proposed health care bill in Washington this weekend show that Republicans have the opportunity to use the bill's passage as a way to foster animosity against the Democrats in this year's mid-term election. If the Republicans can claim more seats in the Senate, they will be in a better position to check the president's plans.

In the special election in Massachusetts in January, a mostly Democratic state voted Republican Scott Brown into the Senate, knowing full well that he would jeopardize health care reform. As a result of the Massachusetts election and the passage of the health care overhaul, it looks likely that November's election will not go well for the Democrats, which faces internal strife from those within who are disenchanted with Obama's reform efforts.

This means that the president's chances of pushing through another hotly contested topic on the legislative agenda, financial reform, are reduced. The financial sector will benefit from Congress's decision on health care and ETFs like Financials SPDR ( XLF) and iShares Dow Jones U.S. Financial Sector Index ETF ( IYF), with a large stake in big financial firms such as Goldman Sachs ( GS), Bank of America ( BAC), J.P. Morgan ( JPM) or Citigroup ( C), could see a boost.

However, this will be a trend that will materialize in the mid- to long-term.

In the short run, the market will interpret the passage of the health care bill as a sign that Obama's political maneuvering powers are in their prime and that he will be able to ram his favored legislation through before mid-term elections. In this case, XLF, and IYF will face downward pressure. The regional bank ETFs will do better because they are not a target of reform.

But as November draws closer, if financial reform is not well on its way to being passed, I expect that the big financials will begin to outperform as the market starts to take into account a Republican victory in the mid-term elections.

-- Written by Don Dion in Williamstown, Mass.
At the time of publication, Dion is long iShares Dow Jones U.S. Pharmaceuticals.

Don Dion is president and founder of Dion Money Management, a fee-based investment advisory firm to affluent individuals, families and nonprofit organizations, where he is responsible for setting investment policy, creating custom portfolios and overseeing the performance of client accounts. Founded in 1996 and based in Williamstown, Mass., Dion Money Management manages assets for clients in 49 states and 11 countries. Dion is a licensed attorney in Massachusetts and Maine and has more than 25 years' experience working in the financial markets, having founded and run two publicly traded companies before establishing Dion Money Management.

Dion also is publisher of the Fidelity Independent Adviser family of newsletters, which provides to a broad range of investors his commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than 100,000 subscribers in the U.S. and 29 other countries, Fidelity Independent Adviser publishes six monthly newsletters and three weekly newsletters. Its flagship publication, Fidelity Independent Adviser, has been published monthly for 11 years and reaches 40,000 subscribers.